SPP2

secreted phosphoprotein 2

Basic information

Region (hg38): 2:234050679-234077134

Links

ENSG00000072080NCBI:6694OMIM:602637HGNC:11256Uniprot:Q13103AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • retinitis pigmentosa (Limited), mode of inheritance: AD
  • retinitis pigmentosa (Limited), mode of inheritance: AD

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
32
clinvar
2
clinvar
36
missense
74
clinvar
3
clinvar
2
clinvar
79
nonsense
6
clinvar
6
start loss
0
frameshift
1
clinvar
3
clinvar
4
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
7
clinvar
7
splice region
2
6
8
non coding
2
clinvar
27
clinvar
3
clinvar
32
Total 0 1 97 62 7

Variants in SPP2

This is a list of pathogenic ClinVar variants found in the SPP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-234050786-C-A SPP2-related disorder Likely benign (Jul 23, 2019)3033178
2-234050796-A-C Likely benign (Feb 19, 2022)2099780
2-234050812-C-G not specified Uncertain significance (Aug 08, 2024)2994475
2-234050812-C-T not specified Conflicting classifications of pathogenicity (Jul 30, 2024)971275
2-234050813-G-T Likely benign (Apr 22, 2024)1133128
2-234050815-T-A Uncertain significance (Nov 04, 2023)2857130
2-234050815-T-C Uncertain significance (Oct 22, 2024)1982068
2-234050834-T-C SPP2-related disorder Likely benign (Feb 03, 2025)731805
2-234050833-T-TTATG Retinal dystrophy Likely pathogenic (Oct 01, 2023)3027529
2-234050836-T-C Uncertain significance (Nov 22, 2022)1380397
2-234050845-T-A Uncertain significance (Dec 07, 2022)2819076
2-234050846-TGGAATGAAC-T Uncertain significance (Jul 26, 2023)2989218
2-234050850-A-G Uncertain significance (Apr 02, 2024)2964092
2-234050855-C-T Likely benign (Nov 13, 2021)1655865
2-234050858-C-T Likely benign (Nov 13, 2021)1616982
2-234050857-A-ATGTTTGCTCTTGGAATTATGT Uncertain significance (Nov 19, 2021)1393042
2-234050861-G-C Uncertain significance (Nov 19, 2021)1449263
2-234050861-GT-CC Uncertain significance (Feb 24, 2024)971622
2-234050866-G-A not specified Uncertain significance (Dec 26, 2023)3169334
2-234050891-G-A Likely benign (Jul 05, 2022)2014210
2-234050957-G-C Likely benign (Jan 23, 2025)1120925
2-234050957-G-T Likely benign (Jan 23, 2025)1142533
2-234050962-C-A Uncertain significance (Oct 29, 2024)1370240
2-234050962-C-T Likely benign (Nov 11, 2024)851783
2-234050963-G-A SPP2-related disorder Likely benign (Aug 30, 2023)1439585

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPP2protein_codingprotein_codingENST00000168148 726456
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.69e-140.002021257070401257470.000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3891361241.100.000006911398
Missense in Polyphen3531.1911.1221369
Synonymous0.006984444.10.9990.00000263362
Loss of Function-1.371812.71.415.35e-7160

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006300.000630
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0001850.000185
Middle Eastern0.00005440.0000544
South Asian0.00006540.0000653
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Could coordinate an aspect of bone turnover. {ECO:0000250}.;
Pathway
Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis (Consensus)

Intolerance Scores

loftool
0.814
rvis_EVS
-0.32
rvis_percentile_EVS
31.69

Haploinsufficiency Scores

pHI
0.0358
hipred
N
hipred_score
0.123
ghis
0.421

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.00449

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Spp2
Phenotype

Gene ontology

Biological process
skeletal system development;platelet degranulation;negative regulation of endopeptidase activity;post-translational protein modification;cellular protein metabolic process;bone remodeling
Cellular component
extracellular region;endoplasmic reticulum lumen;platelet dense granule lumen;collagen-containing extracellular matrix
Molecular function
endopeptidase inhibitor activity